FUNDAMENTALS · Fundamentals · US Healthcare

Elevance Health (ELV) Fundamentals 2026 — P/E 17.2x, Revenue Analysis | SniperIQ

Elevance Health (ELV) is a US-listed Healthcare company in Medical - Healthcare Plans with a market capitalization of $84.1B, trading at

87.84 on the NYSE. This SniperIQ fundamentals page covers Elevance Health's valuation (P/E 17.2x, P/B 1.9x), profitability (net margin 2.5%), revenue (
99.1B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap$84.1B
P/E (TTM)17.2x
Net Margin2.5%
Revenue (FY25)
99.1B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Elevance Health's market cap?

Elevance Health (ELV) has a market capitalization of approximately $84.1B, trading at

87.84 on the NYSE. Market cap moves with the live share price.

What is Elevance Health's P/E ratio?

Elevance Health's trailing twelve-month P/E ratio is 17.2x, with a price-to-book (P/B) of 1.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Elevance Health?

Elevance Health runs a net profit margin of 2.5%, a gross margin of 39.0%, and an operating margin of 3.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Elevance Health generate?

Elevance Health reported revenue of

99.1B for fiscal year 2025, with net income of $5.7B and earnings per share (EPS) of 25.18. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Elevance Health pay a dividend?

Elevance Health offers a trailing dividend yield of about 1.8%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Elevance Health financially healthy?

Elevance Health carries a debt-to-equity ratio of 0.69x and a current ratio of 1.52x, with a market beta of 0.68. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Elevance Health a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Elevance Health (ELV) the key facts are: market cap $84.1B, P/E 17.2x, revenue

99.1B, 52-week range 273.71-436.24. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Elevance Health's full fundamentals live

Get Elevance Health's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.